GCNT2-mediated alterations in N-glycosylation modulate SHBG levels, insulin sensitivity, and ovarian function, directly linking metabolic disruptions to PCOS clinical manifestations. The gene discussed is SHBG; the disease is polycystic ovary syndrome.